Ballentine Partners’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,386
| Closed | -$55.2K | – | 688 |
|
|
2023
Q3 | $55.2K | Buy |
10,386
+281
| +3% | +$1.49K | ﹤0.01% | 594 |
|
|
2023
Q2 | $96.3K | Sell |
10,105
-88
| -0.9% | -$839 | ﹤0.01% | 583 |
|
|
2023
Q1 | $112K | Buy |
+10,193
| New | +$112K | ﹤0.01% | 543 |
|
|
2021
Q3 | – | Sell |
-7,377
| Closed | -$201K | – | 422 |
|
|
2021
Q2 | $201K | Buy |
+7,377
| New | +$201K | 0.01% | 401 |
|